Clinical Trials Browser

Anemia, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00022607 2013-06-24

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00026520 2013-06-24

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Dermatologic

Melanoma

NCT00006005 2013-06-21

Thalidomide in Treating Patients With Gynecologic Sarcomas

Phase 2 Completed

GynecologicSarcoma

Sarcoma, Endometrial Neoplasms, Sarcoma, Endometrial Stromal

NCT00009984 2013-06-06

Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer

Phase 2 Terminated

70 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00046826 2013-04-04

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

Phase 2 Completed

Genitourinary

Prostatic Neoplasms

NCT00017316 2013-02-11

Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

35 enrolled

Dermatologic

Melanoma

NCT00003850 2013-02-08

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

47 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00015912 2013-01-25

Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Terminated

35 enrolled

Lymphoid

Lymphoma, Follicular

NCT00015990 2013-01-24

Thalidomide in Treating Patients With Myelodysplastic Syndrome

Phase 2 Completed

29 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

NCT00025467 2013-01-24

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

60 enrolled

Gynecologic

Endometrial Neoplasms

NCT00062127 2013-01-24

Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

35 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00072163 2013-01-17

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Phase 2 Completed

50 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00083005 2012-03-15

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Phase 2 Completed

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT00047879 2011-10-26

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

Phase 2 Completed

7 enrolled 8 charts

CNS

Brain Neoplasms, Glioma

NCT00438841 2009-03-13

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Phase 2 Unknown

43 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00005966 2009-02-05

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 3 Completed

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00001446 2008-03-04

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Phase 2 Completed

64 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00001475 2008-03-04

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Phase 2 Completed

85 enrolled

Acquired Immunodeficiency Syndrome, HIV Infections

NCT00001524 2008-03-04

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

Phase 2 Completed

110 enrolled

Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome, Stomatitis, Aphthous, HIV Infections, Oral Ulcer

NCT00006200 2005-06-24

Thalidomide and Dacarbazine for Metastatic Melanoma

Phase 2 Unknown

Dermatologic

Melanoma